Contrary to the stimulation observed with estrogens and androgens in breast cancer cells, DHT and synthetic androgens (R1881) inhibit UGT2B15 expression and activity in LNCaP cells [48]. This evidence concerns the gene UGT2B15 and breast carcinoma.